# Development of an Antiviral to Combat Viral Infections

> **NIH NIH N01** · BARUCH S. BLUMBERG INSTITUTE · 2024 · $4,020,000

## Abstract

To support the advanced development of candidate therapeutics for various viral pathogens, including coronavirus and yellow fever, covered under the Antiviral Program for Pandemics. The supported research and development activities will progress the therapeutic product development and may include lead optimization, candidate selection, preclinical and IND enabling studies, Chemistry, Manufacturing, and Controls (CMC), IND submission, clinical safety and efficacy assessment.

## Key facts

- **NIH application ID:** 11196795
- **Project number:** 75N93023C00003-P00004-9999-2
- **Recipient organization:** BARUCH S. BLUMBERG INSTITUTE
- **Principal Investigator:** JINHONG CHANG
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $4,020,000
- **Award type:** —
- **Project period:** 2022-11-15 → 2025-04-17

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11196795

## Citation

> US National Institutes of Health, RePORTER application 11196795, Development of an Antiviral to Combat Viral Infections (75N93023C00003-P00004-9999-2). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/11196795. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*